Breaking News Instant updates and real-time market news.

CLCD

CoLucid Pharmaceuticals

$36.15

-0.15 (-0.41%)

07:01
12/22/16
12/22
07:01
12/22/16
07:01

CoLucid Pharmaceuticals initiated with a Buy at BTIG

BTIG analyst Robert Hazlett initiated CoLucid with a Buy and a $58 price target.

CLCD CoLucid Pharmaceuticals
$36.15

-0.15 (-0.41%)

09/15/16
PIPR
09/15/16
NO CHANGE
Target $36
PIPR
Overweight
CoLucid price target raised to $36 from $21 at Piper Jaffray
Piper Jaffray analyst Charles Duncan raised his price target for CoLucid Pharmaceuticals to $36 saying the positive Phase III results from lasmiditan de-risk further development of the "novel mechanism" in acute migraine. The analyst reiterates an Overweight rating on the shares.
09/19/16
LTCO
09/19/16
NO CHANGE
Target $57
LTCO
Buy
CoLucid could have takeout potential following lasmiditan data, says Ladenburg
After CoLucid presented additional detail on its Phase 3 pivotal trial evaluating lasmiditan, the "SAMURAI" study, Ladenburg Thalmann analyst Robert Hazlett said the additional details support the drug's efficacy in the treatment of acute migraine. Hazlett now includes the potential for a takeover in his valuation of the stock, explaining that he values CoLucid at $45.71 per share as a stand-alone entity and values it at $68.13 per share using a takeover scenario, arriving at a raised $57 price target, up from his prior target of $52. Hazlett maintains a Buy rating on CoLucid shares, which are up about 4% to $29.19 in pre-market trading.
12/15/16
LEHM
12/15/16
INITIATION
Target $45
LEHM
Overweight
CoLucid Pharmaceuticals initiated with an Overweight at Barclays
Barclays analyst Douglas Tsao started CoLucid Pharmaceuticals with an Overweight rating and $45 price target. The analyst sees peak sales of over $700M for the company's lead asset lasmiditan, an oral non-vasoconstrictive drug in episodic migraine.
12/21/16
PIPR
12/21/16
NO CHANGE
PIPR
Piper lays out top BioPharma picks for 2017
Piper Jaffray analysts laid out their top BioPharma picks for 2017. Analyst Richard Purkiss favors Pfizer (PFE) and Eli Lilly (LLY) as his top large pharma picks. Analyst Joshua Schimmer calls Gilead (GILD) and Alexion (ALXN) his top large cap picks. Analyst David Amsellem names Horizon Pharma (HZNP) his top specialty pharma pick. Piper's other top Biopharma picks for 2017 include ACADIA (ACAD), Aimmune (AIMT), Akorn (AKRX), Alnylam (ALNY), Axovant Sciences (AXON), Cara Therapeutics (CARA), CoLucid Pharmaceuticals (CLCD), Eale Pharmaceuticals (EGRX), Exelixis (EXEL), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Neurocrine (NBIX), Nektar (NKTR), Otonomy (OTIC), Reata Pharmaceuticals (RETA), Rigel Pharmaceuticals (RIGL), Ignyta (RXDX), Theravance Biopharma (TBPH), Versartis (VSAR) and Voyager Therapeutics (VYGR). The analysts look for recent momentum in BioPharma to continue in 2017. They believe innovation and potentially repatriation should lead to increased merger activity.

TODAY'S FREE FLY STORIES

BXE

Bellatrix Exploration

$2.40

-0.03 (-1.23%)

17:49
08/16/17
08/16
17:49
08/16/17
17:49
Hot Stocks
Bellatrix Exploration regains NYSE minimum price compliance »

Bellatrix Exploration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$42.41

0.44 (1.05%)

17:48
08/16/17
08/16
17:48
08/16/17
17:48
Hot Stocks
NetApp says headwind for services revenue to decrease in coming quarters »

Comments from Q1 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

  • 14

    Sep

ACHN

Achillion

$4.88

-0.12 (-2.40%)

17:45
08/16/17
08/16
17:45
08/16/17
17:45
Conference/Events
Achillion management to meet with William Blair »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

BCOR

Blucora

$23.35

0.1 (0.43%)

, BBOX

Black Box

$3.75

-0.25 (-6.25%)

17:35
08/16/17
08/16
17:35
08/16/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Blucora (BCOR),…

BCOR

Blucora

$23.35

0.1 (0.43%)

BBOX

Black Box

$3.75

-0.25 (-6.25%)

BGG

Briggs & Stratton

$24.09

0.29 (1.22%)

LB

L Brands

$39.55

0.5 (1.28%)

VIPS

Vipshop

$11.10

-0.07 (-0.63%)

SPTN

SpartanNash

$25.96

0.07 (0.27%)

SNPS

Synopsys

$79.09

0.86 (1.10%)

CSCO

Cisco

$32.34

0.25 (0.78%)

NTAP

NetApp

$42.41

0.44 (1.05%)

LAKE

Lakeland Industries

$15.65

-0.25 (-1.57%)

GCP

GCP Applied Technologies

$28.75

0.1 (0.35%)

FNGN

Financial Engines

$34.35

-0.1 (-0.29%)

ACHC

Acadia

$51.68

-0.33 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

  • 29

    Aug

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 14

    Sep

  • 30

    Nov

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

ANDX

Andeavor Logistics

$46.94

0.12 (0.26%)

, WNRL

Western Refining Logistics

$24.25

0.1 (0.41%)

17:26
08/16/17
08/16
17:26
08/16/17
17:26
Upgrade
Andeavor Logistics, Western Refining Logistics rating change  »

Andeavor Logistics…

ANDX

Andeavor Logistics

$46.94

0.12 (0.26%)

WNRL

Western Refining Logistics

$24.25

0.1 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$200.61

1.12 (0.56%)

17:22
08/16/17
08/16
17:22
08/16/17
17:22
Hot Stocks
General Dynamics awarded $115.3M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

BLVD

Boulevard Acquisition

$10.04

-0.01 (-0.10%)

17:17
08/16/17
08/16
17:17
08/16/17
17:17
Hot Stocks
Breaking Hot Stocks news story on Boulevard Acquisition »

Glazer Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMBH

First Mid-Illinois Bancshares

$34.85

-0.33 (-0.94%)

17:17
08/16/17
08/16
17:17
08/16/17
17:17
Syndicate
First Mid-Illinois Bancshares files to sell $20M of common stock 'at-the-market' »

First Mid-Illinois…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

NCOM

National Commerce

$39.55

0.1 (0.25%)

17:16
08/16/17
08/16
17:16
08/16/17
17:16
Hot Stocks
National Commerce, FirstAtlantic Financial sign definitive merger agreement »

National Commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

AMGN

Amgen

$171.39

1.35 (0.79%)

17:13
08/16/17
08/16
17:13
08/16/17
17:13
Hot Stocks
Amgen: NEJM publishes results from Repatha cognitive function trial »

Amgen announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 18

    Aug

  • 08

    Sep

  • 14

    Sep

  • 02

    Dec

  • 03

    Feb

  • 17

    May

WLK

Westlake Chemical

$71.03

0.84 (1.20%)

17:13
08/16/17
08/16
17:13
08/16/17
17:13
Hot Stocks
Westlake Chemical CFO Mark Bender sells 13,794 shares of company stock »

Mark Bender, Westlake…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBOX

Black Box

$3.75

-0.25 (-6.25%)

17:10
08/16/17
08/16
17:10
08/16/17
17:10
Hot Stocks
Black Box director John Heller buys 10,000 shares of company stock »

Black Box director John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCOR

Blucora

$23.35

0.1 (0.43%)

17:07
08/16/17
08/16
17:07
08/16/17
17:07
Hot Stocks
Blucora director retires from board effective August 10 »

Elizabeth J. Huebner, who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGG

Briggs & Stratton

$24.09

0.29 (1.22%)

17:06
08/16/17
08/16
17:06
08/16/17
17:06
Earnings
Briggs & Stratton sees FY18 EPS $1.31-$1.48, consensus $1.38 »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGG

Briggs & Stratton

$24.09

0.29 (1.22%)

17:05
08/16/17
08/16
17:05
08/16/17
17:05
Earnings
Briggs & Stratton reports Q4 EPS 46c, consensus 53c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$32.34

0.25 (0.78%)

17:02
08/16/17
08/16
17:02
08/16/17
17:02
Hot Stocks
Breaking Hot Stocks news story on Cisco »

Cisco says order booking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

MED

Medifast

$51.63

-0.4 (-0.77%)

16:58
08/16/17
08/16
16:58
08/16/17
16:58
Initiation
Medifast initiated  »

Medifast initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSKE

Daseke

$12.11

-0.1 (-0.82%)

16:57
08/16/17
08/16
16:57
08/16/17
16:57
Hot Stocks
Daseke completes term loan amendment to support growth strategy »

Daseke announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

QEP

QEP Resources

$7.09

-0.2 (-2.74%)

16:55
08/16/17
08/16
16:55
08/16/17
16:55
Hot Stocks
Breaking Hot Stocks news story on QEP Resources »

Integrated Core…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$32.34

0.25 (0.78%)

16:50
08/16/17
08/16
16:50
08/16/17
16:50
Hot Stocks
Cisco to realign reporting into 5 distinct categories starting in 1Q18 »

Says innovation "as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

LB

L Brands

$39.55

0.5 (1.28%)

16:48
08/16/17
08/16
16:48
08/16/17
16:48
Hot Stocks
L Brands sees FY17 SSS down low to mid-single digits »

Sees FY17 SSS excluding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

LB

L Brands

$39.55

0.5 (1.28%)

16:46
08/16/17
08/16
16:46
08/16/17
16:46
Hot Stocks
L Brands sees Q3 SSS flat to down low-single digits »

Sees Q3 SSS excluding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

LGL

LGL Group

$4.31

0.0012 (0.03%)

16:40
08/16/17
08/16
16:40
08/16/17
16:40
Hot Stocks
LGL Group announces terms for rights offering »

The LGL Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLST

Netlist

$0.84

-0.06 (-6.67%)

16:37
08/16/17
08/16
16:37
08/16/17
16:37
Syndicate
Netlist files to sell common stock, no amount given »

Craig-Hallum Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRAH

PRA Health

$75.16

-0.54 (-0.71%)

16:34
08/16/17
08/16
16:34
08/16/17
16:34
Initiation
PRA Health initiated  »

PRA Health initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.